TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14636 · Apr 27

#powershell#automated#bloatware#bloatware_removal#cleanup#debloat#debloater#interactive#optimize#powershell#powershell_script#privacy#ps1#registry_tweaks#tweaks#windows#windows_10#windows_11#windows_11_debloat#windows10#windows11 Win11Debloat is a free PowerShell script that quickly removes pre-installed Windows bloatware like TikTok, Xbox Game Bar, and Copilot while disabling ads, telemetry, and intrusive features. It simplifies tasks like restoring the classic right-click menu, hiding duplicate drives in File Explorer, and removing taskbar clutter, saving you from manually adjusting settings. The script is safe, reversible, and improves your experience by eliminating unnecessary background processes and distractions, making Windows cleaner and more focused. https://github.com/Raphire/Win11Debloat

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment